Knockdown of KRT17 may also decrease the viability and Warburg effect of osteosarcoma cells by significantly affecting the AKT/mTOR/hypoxia-inducible factor 1α (HIF1α) pathway and interrupting the expression of relevant genes [35]. The gene discussed is AKT1; the disease is osteosarcoma.